Quest Laboratories (NSE:QUESTLAB) 1-Year Sharpe Ratio: 0.62 (As of Jul. 01, 2026)


NSE:QUESTLAB Quest Laboratories Ltd NSE:QUESTLAB
44 GF Score
Price ₹98.10
! 7 Warning Signs
View Full Analysis

What is Quest Laboratories 1-Year Sharpe Ratio?

Quest Laboratories NSE:QUESTLAB +0.15% 44 1-Year Sharpe Ratio is 0.62 as of Jul. 01, 2026. GuruFocus rates NSE:QUESTLAB with a GF Score™ of 44/100. The stock has 7 warning signs investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-07-01), Quest Laboratories's 1-Year Sharpe Ratio is 0.62.

Quest Laboratories  (NSE:QUESTLAB) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

Quest Laboratories 1-Year Sharpe Ratio Related Terms

NSE:QUESTLAB vs LLY, JNJ, ABBV: 1-Year Sharpe Ratio Comparison

For the Drug Manufacturers - General subindustry, Quest Laboratories's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Quest Laboratories 1-Year Sharpe Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Quest Laboratories's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Quest Laboratories's 1-Year Sharpe Ratio falls into.


NSE:QUESTLAB
44GF Score
Quest Laboratories Ltd NSE:QUESTLAB
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Quest Laboratories 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of 0.62 mean?
Quest Laboratories (NSE:QUESTLAB) has a 1-Year Sharpe Ratio of 0.62 as of Jul. 01, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Quest Laboratories and its competitors.
Is Quest Laboratories' 1-Year Sharpe Ratio too high?
Quest Laboratories' current 1-Year Sharpe Ratio is 0.62. Overall, Quest Laboratories has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Quest Laboratories' 1-Year Sharpe Ratio compare to LLY and JNJ?
Quest Laboratories' 1-Year Sharpe Ratio of 0.62 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Drug Manufacturers company?
A good 1-Year Sharpe Ratio depends on the Drug Manufacturers industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Quest Laboratories and its competitors. Quest Laboratories's current 1-Year Sharpe Ratio is 0.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quest Laboratories stock overvalued right now?
Quest Laboratories (NSE:QUESTLAB) has a current 1-Year Sharpe Ratio of 0.62. The current 1-Year Sharpe Ratio is 0.62. Quest Laboratories' overall GF Score™ is 44/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For Quest Laboratories (NSE:QUESTLAB), the current 1-Year Sharpe Ratio is 0.62 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Quest Laboratories Business Description

Address Sector III, Plot No. 45, Pithampur Industrial Area, Opposite Kissan Pipe Unit 4, District Dhar, Pithampur, Dhar, MP, IND, 454775
Quest Laboratories Ltd is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces various products, comprising ethical drugs, generic drugs, and over-the-counter drugs, and is also available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids, among others. The company operates in a single segment of Drugs and Chemicals.
44GF Score

Get the complete analysis for NSE:QUESTLAB

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹98.10
Price